3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
4
Phase 2
3
Phase NA
2
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
2
Classical hematology
1
Conditions
Anemia
30
Neoplasms
21
Febrile Neutropenia
19
Venous Thromboembolism
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Neutropenia
5
Leukemia, Myeloid, Acute
5
Colorectal Neoplasms
5
Pulmonary Embolism
4
Myelodysplastic Syndromes
4
Leukemia
4
Fever
4
Anemia, Iron-Deficiency
4
Venous Thrombosis
3
Thrombocytopenia
3
Ovarian Neoplasms
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Hematologic Neoplasms
3
Breast Neoplasms
3
Adenocarcinoma
3
Vitamin D Deficiency
2
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sepsis
2
Recurrence
2
Postoperative Complications
2
Lymphoma, Follicular
2
Lymphoma
2
Infections
2
Interventions
ferric carboxymaltose
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lymphoproliferative Disorders
×
Classical hematology
×
Clear all
NCT01100879
2022-05-09
AOC-MM
Vifor Pharma
Phase 4
Terminated
3 enrolled